Astrocytoma Idh-mutant Who
📧 Sign up to get email alerts when something new happens for Astrocytoma Idh-mutant Who.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma [Phase 1]
This is a Phase 1 clinical trial evaluating intracranial TGFβR2KO/IL13Rα2 CAR T-cells for recurrent glioblastoma and IDH-mutant astrocytoma …
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma [Phase 1]
Phase 1 clinical trial update evaluating intrathecal azacitidine in combination with nivolumab for recurrent high-grade glioma. The study is…